Narrow by location

DOT Changes Drug Testing List

Safety

The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:

  • Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
  • Hydromorphone – Trade name Dilasudid
  • Oxymorphone – Trade name Numorphan
  • Oxycodone – Trade name Eucodal

DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.

This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

 

Recap of the Pending ANSI/CSA Standards for Aerial Lifts

By Scott Owyen, Construction Executive EVERYTHING IS CHANGING FOR CONTRACTORS ANSI (United States) and CSA (Canada) standards have,... »

An Inside Job: Use Indoor Construction Cameras to Monitor Workflow and Safety

By Ken Pittman, Construction Executive Managing jobsites can be challenging enough, but once interior work begins and crews... »

Drug/Alcohol Test Standards for CMV Drivers

from Turner Insurance & Bonding According to the U.S. Department of Transportation, professional drivers and others behind the... »

Medical Marijuana and the DOT: Understanding the Guidelines

from Turner Insurance & Bonding Twenty eight states and the District of Columbia have legislation legalizing the use... »

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *